Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment
Elevated plasma total homocysteine (tHcy) is associated with the development of Alzheimer's disease and other forms of dementia. In this study, we report the relationship between tHcy and epigenetic age in older adults with mild cognitive impairment from the VITACOG study. Epigenetic age and ra...
Hauptverfasser: | Holmes, HE, Valentin, RE, Jernerén, F, de Jager Loots, CA, Refsum, H, Smith, AD, Guarente, L, Dellinger, RW, Sampson, D, Alzheimer's Disease Neuroimaging Initiative |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
Wiley Open Access
2024
|
Ähnliche Einträge
Ähnliche Einträge
-
Random forest prediction of Alzheimer's disease using pairwise selection from time series data
von: Moore, P, et al.
Veröffentlicht: (2019) -
Two for tau: automated model discovery reveals two-stage tau aggregation dynamics in Alzheimer’s disease
von: Stockman, CA, et al.
Veröffentlicht: (2024) -
Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
von: Oulhaj, A, et al.
Veröffentlicht: (2016) -
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
von: de Jager, C, et al.
Veröffentlicht: (2012) -
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
von: De Jager, C, et al.
Veröffentlicht: (2012)